Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 7/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | ACACB | O00763 | 1/20 | 0.37 |
| ▸ | ACACA | Q13085 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23578220 | 1.00 | GSTP1 (0.40) | GSTP1MAPK1MAPTFFAR1TP53 | |
| SCHEMBL23588141 | 0.88 | GSTP1 (0.43) | GSTP1MAPK1MAPTFFAR1TP53 | |
| SCHEMBL23588077 | 0.86 | ACACB (0.52) | MAPTFFAR1TP53ACACBACACA | |
| SCHEMBL27291368 | 0.84 | ACACB (0.39) | GSTP1MAPTTP53ACACBACACA | |
| SCHEMBL23588102 | 0.80 | SPHK1 (0.48) | MAPTFFAR1TP53 | |
| SCHEMBL23588271 | 0.79 | SPHK1 (0.53) | — | |
| SCHEMBL23588349 | 0.79 | TP53 (0.41) | GSTP1TP53 | |
| SCHEMBL23588068 | 0.79 | SPHK2 (0.42) | MAPK1TP53 | |
| SCHEMBL31707540 | 0.78 | ACACB (0.38) | MAPTTP53ACACBACACA | |
| SCHEMBL25802125 | 0.78 | MEN1 (0.46) | GSTP1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4081511-B3 | CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES | SITRYX THERAPEUTICS LTD (GB) | 2026-03-04 | — | — | EP | disclosed |
| EP-4081511-A1 | CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES | Sitryx Therapeutics Limited (GB) | 2022-11-02 | — | — | EP | disclosed |